1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, November 2016 (p8)

Biological Therapy Analysis & Statistics, November 2016 (p8)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

211-240 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies

BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies

  • $ 220
  • Industry report
  • November 2016
  • by La Merie Publishing

BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information about Bispecific Antibodies released during the month of Octobe ...

  • Industries : Biological Therapy
BCMA-Targeted Antibodies & T-Cells in: October 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

BCMA-Targeted Antibodies & T-Cells in: October 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells

  • $ 220
  • Industry report
  • November 2016
  • by La Merie Publishing

BCMA-Targeted Antibodies & T-Cells in: October 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains information about TCR & CAR engineered T-cells and NK cells ...

  • Industries : Biological Therapy
Flat-Rate Access to R&D Database & Reports from La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

  • $ 8470
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing - R&D Drug Pipeline Database: 1-Year Subscription - Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-yea ...

  • Industries : Biological Therapy
Global Cell Therapy Market & Clinical Pipeline Outlook 2022

Global Cell Therapy Market & Clinical Pipeline Outlook 2022

  • $ 2400
  • Industry report
  • November 2016
  • by Kuick Research

“Global Cell Therapy Market & Clinical Pipeline Outlook 2022” report published by Kuick Research gives comprehensive insight on the ongoing clinical and nonclinical trends in the global cell therapy ...

  • Industries : Biological Therapy
  • Countries : World
Tissue Engineering - Global Market Outlook (2016-2022)

Tissue Engineering - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Tissue Engineering market is expected to grow from $6.24 billion in 2015 to reach $14.86 billion by 2022 with a CAGR of 13.2%. Growing usage of tissue engineering ...

  • Industries : Biological Therapy
  • Countries : World, Asia, North America, Europe
Flat-Rate Subscription to La Merie Publishing Reports & News Services

Flat-Rate Subscription to La Merie Publishing Reports & News Services

  • $ 5500
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-year subscription to this service provides access to - all existing La Merie Publishing reports on stock and listed online in ...

  • Industries : Biological Therapy
Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)

Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)

  • $ 900
  • Industry report
  • November 2016
  • by Daedal Research

Scope of the Report The report titled “Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)”, provides an in-depth analysis of the global allergy immunotherapy market by value, ...

  • Industries : Biological Therapy
  • Countries : World
Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts

Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • November 2016
  • by Currentpartnering

The Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the stem cell partnering deals and agreements ...

  • Industries : Biological Therapy, Biotechnology, Pathology, Healthcare
  • Countries : United States
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion ...

  • Industries : Pathology, Therapy, Biological Therapy, Pharmaceutical
  • Countries : United States, World
Interleukin 13 (IL13) - Pipeline Review, H2 2016

Interleukin 13 (IL13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Interleukin 13 (IL13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 13 (IL13) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 13 (IL13) targeted ...

  • Industries : Therapy, Pathology, Chronic Disease, Biological Therapy
  • Countries : United States
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Telomerase ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical
  • Countries : United States, World
Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016

Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016" provides an overview of Alcoholic ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : World
Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016

Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World
Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2016

Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : World
Liposarcoma Global Clinical Trials Review, H2, 2016

Liposarcoma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Liposarcoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Liposarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Liposarcoma clinical trials ...

  • Industries : Cancer, Health Facility, Pathology, Therapy
  • Countries : World
Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016

Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : World
Angiosarcoma Global Clinical Trials Review, H2, 2016

Angiosarcoma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Angiosarcoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Angiosarcoma clinical trials ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : World
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy, Healthcare
  • Countries : World
Hematological Tumor Global Clinical Trials Review, H2, 2016

Hematological Tumor Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Hematological Tumor Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Hematological Tumor Global Clinical Trials Review, H2, 2016" provides an overview of Hematological ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World
Sickle Cell Disease - Pipeline Review, H2 2016

Sickle Cell Disease - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Sickle Cell Disease - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sickle Cell Disease - Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology, Healthcare
  • Countries : United States
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • October 2016
  • by Global Markets Direct

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, ...

  • Industries : Cancer, Pathology, Biotechnology, Biological Therapy
  • Countries : United States
Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States
Head And Neck Cancer - Pipeline Review, H2 2016

Head And Neck Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • October 2016
  • by Global Markets Direct

Head And Neck Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer - Pipeline Review, H2 2016, provides an ...

  • Industries : Healthcare, General Medicine and Specialty Medicine
  • Countries : United States
Ageing - Pipeline Review, H2 2016

Ageing - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Ageing - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ageing - Pipeline Review, H2 2016, provides an overview of the Ageing (Metabolic ...

  • Industries : Drug Discovery and Development, Biological Therapy, Therapy, Pharmaceutical
  • Countries : World
Angina (Angina Pectoris) - Pipeline Review, H2 2016

Angina (Angina Pectoris) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Angina (Angina Pectoris) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2016

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glial Cell Line Derived Neurotrophic Factor (Astrocyte ...

  • Industries : Mental Health, Pathology, Biological Therapy
  • Countries : World, Europe
Bioprinting: Technologies and Global Markets

Bioprinting: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Understand market dynamics of bioprinting technologies, applications, and end-user industries. - Assess specific bioprinting-related industries, including 3-D cell culture; bioinks; ...

  • Industries : Biological Therapy
  • Countries : World
C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H2

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H2

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Recepto ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Epidermolysis Bullosa - Pipeline Review, H2 2016

Epidermolysis Bullosa - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Epidermolysis Bullosa - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology
  • Countries : United States
Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hematopoietic Stem Cell Transplantation - ...

  • Industries : Biological Therapy, Blood Supply, Tissue Banking and Transplantation, Pathology, Biotechnology, Cancer, Healthcare
  • Countries : United States

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.